Dizal Pharmaceutical resubmits listing application to Hong Kong Stock Exchange
Dizal Pharmaceutical has resubmitted its listing application to the Hong Kong Stock Exchange.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.